Topiramate Approved for Migraine Prevention in Adolescents (FREE)

By Amy Orciari Herman The FDA has approved the antiepileptic topiramate (Topamax) to prevent migraine in adolescents aged 12 to 17, the agency announced on Friday. It's the first drug approved for …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news